Rubrofusarin-6-O-beta-D-gentiobiosideCAS# 24577-90-0 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 24577-90-0 | SDF | Download SDF |
| PubChem ID | 503733 | Appearance | Powder |
| Formula | C27H32O15 | M.Wt | 596.5 |
| Type of Compound | Phenols | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 5-hydroxy-8-methoxy-2-methyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxybenzo[g]chromen-4-one | ||
| SMILES | CC1=CC(=O)C2=C(O1)C=C3C=C(C=C(C3=C2O)OC4C(C(C(C(O4)COC5C(C(C(C(O5)CO)O)O)O)O)O)O)OC | ||
| Standard InChIKey | JIBJMBHKGBDCPN-IJTBWITGSA-N | ||
| Standard InChI | InChI=1S/C27H32O15/c1-9-3-12(29)18-13(39-9)5-10-4-11(37-2)6-14(17(10)21(18)32)40-27-25(36)23(34)20(31)16(42-27)8-38-26-24(35)22(33)19(30)15(7-28)41-26/h3-6,15-16,19-20,22-28,30-36H,7-8H2,1-2H3/t15-,16-,19-,20-,22+,23+,24-,25-,26-,27-/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Rubrofusarin-6-O-beta-D-gentiobioside can significantly decrease the expression of TGF-beta1 and fibronectin and NF-kappaB DNA binding activity, suggests that it has potential as a preventive agent for advanced glycation end products-related diabetic complications. |
| Targets | TGF-β/Smad | NF-kB | ERK | MAPK |
Rubrofusarin-6-O-beta-D-gentiobioside Dilution Calculator
Rubrofusarin-6-O-beta-D-gentiobioside Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.6764 mL | 8.3822 mL | 16.7645 mL | 33.5289 mL | 41.9111 mL |
| 5 mM | 0.3353 mL | 1.6764 mL | 3.3529 mL | 6.7058 mL | 8.3822 mL |
| 10 mM | 0.1676 mL | 0.8382 mL | 1.6764 mL | 3.3529 mL | 4.1911 mL |
| 50 mM | 0.0335 mL | 0.1676 mL | 0.3353 mL | 0.6706 mL | 0.8382 mL |
| 100 mM | 0.0168 mL | 0.0838 mL | 0.1676 mL | 0.3353 mL | 0.4191 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- TC-G 1000
Catalog No.:BCC7991
CAS No.:245744-18-7
- RWJ 52353
Catalog No.:BCC6086
CAS No.:245744-10-9
- (+)-Muscarine iodide
Catalog No.:BCC7556
CAS No.:24570-49-8
- 5'-S-Methyl-5'-thioadenosine
Catalog No.:BCN5108
CAS No.:2457-80-9
- 7,8,9-Trimethoxy-10H-1,3-dioxolo[4,5-b]xanthen-10-one
Catalog No.:BCN1477
CAS No.:24562-58-1
- (2S,3R,E)-2-Amino-4-tetradecene-1,3-diol
Catalog No.:BCN1478
CAS No.:24558-60-9
- Decursitin D
Catalog No.:BCN3908
CAS No.:245446-61-1
- LED209
Catalog No.:BCC6437
CAS No.:245342-14-7
- FSLLRY-NH2
Catalog No.:BCC6279
CAS No.:245329-02-6
- LRGILS-NH2
Catalog No.:BCC3955
CAS No.:245329-01-5
- Makisterone A 20,22-monoacetonide
Catalog No.:BCN7090
CAS No.:245323-24-4
- 1,2-Dioleoyl-sn-glycerol
Catalog No.:BCC6416
CAS No.:24529-88-2
- trans-4-Hydroxycrotonic acid
Catalog No.:BCC6685
CAS No.:24587-49-3
- BIIE 0246
Catalog No.:BCC7158
CAS No.:246146-55-4
- H-Phe-OBzl.HCl
Catalog No.:BCC3006
CAS No.:2462-32-0
- AL 8810
Catalog No.:BCC5366
CAS No.:246246-19-5
- 3-Geranyl-4-methoxybenzoic acid
Catalog No.:BCN5109
CAS No.:246266-38-6
- H-Isoleucinol
Catalog No.:BCC2726
CAS No.:24629-25-2
- Stellasterol
Catalog No.:BCN5110
CAS No.:2465-11-4
- Neolitsine
Catalog No.:BCN4817
CAS No.:2466-42-4
- 3-Amino-2,6-piperidinedione hydrochloride
Catalog No.:BCC8606
CAS No.:24666-56-6
- Catharanthine
Catalog No.:BCN1255
CAS No.:2468-21-5
- Ro 64-5229
Catalog No.:BCC7513
CAS No.:246852-46-0
- 1-Benzoyl-4-oxopiperidine
Catalog No.:BCC8455
CAS No.:24686-78-0
Naphthopyrone glucosides from the seeds of Cassia tora with inhibitory activity on advanced glycation end products (AGEs) formation.[Pubmed:16903080]
Arch Pharm Res. 2006 Jul;29(7):587-90.
Three naphthopyrone glucosides, cassiaside (1), Rubrofusarin-6-O-beta-D-gentiobioside (2), and toralactone-9-O-beta-D-gentiobioside (3), were isolated from the BuOH-soluble extract of the seeds of Cassia tora as active constituents, using an in vitro bioassay based on the inhibition of advanced glycation end products (AGEs) to monitor chromatographic fractionation. The structures of 1-3 were determined by spectroscopic data interpretation, particularly by extensive 1D and 2D NMR studies. All the isolates (1-3) were evaluated for the inhibitory activity on AGEs formation in vitro.
Extract of Cassiae Semen and its major compound inhibit S100b-induced TGF-beta1 and fibronectin expression in mouse glomerular mesangial cells.[Pubmed:20483351]
Eur J Pharmacol. 2010 Sep 1;641(1):7-14.
Non-enzymatic glycation reactions between reducing sugar and free reactive amino groups of protein lead to the formation of advanced glycation end products, which increase under conditions of aging or diabetes. A previous study showed that extracts of Cassiae Semen (CS), the seed of Cassia tora, had inhibitory activity on advanced glycation end products formation in vitro. To examine the pharmacological effects of a butanol-soluble extract of CS under conditions of diabetic nephropathy, we evaluated the expression of transforming growth factor-beta1 (TGF-beta1) and fibronectin, key mediators of diabetic nephropathy, in mouse glomerular mesangial cells cultured in the presence of S100b (a specific ligand for receptor of advanced glycation end products). CS inhibited S100b-induced TGF-beta1 and fibronectin expression in mouse mesangial cells by suppressing activation of Smad2/3, extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK), and oxidative stress. Moreover, CS suppressed nuclear factor-kappa B (NF-kappaB) activation in S100b-stimulated mouse mesangial cells. To identify the active compounds of CS, three major compounds, Rubrofusarin-6-O-beta-D-gentiobioside (CS-A), toralactone-9-O-beta-d-gentiobioside (CS-B), and cassiaside (CS-C), were tested in cells. Of these compounds, CS-A significantly decreased the expression of TGF-beta1 and fibronectin and NF-kappaB DNA binding activity. These findings suggest that CS, especially CS-A, has potential as a preventive agent for advanced glycation end products-related diabetic complications.
